• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病中结直肠癌的化学预防?叶酸的潜在作用。

Chemoprevention of colorectal cancer in inflammatory bowel disease? A potential role for folate.

作者信息

Mouzas I A, Papavassiliou E, Koutroubakis I

机构信息

Gastroenterology Department, University Hospital, Heraklion, Greece.

出版信息

Ital J Gastroenterol Hepatol. 1998 Aug;30(4):421-5.

PMID:9789142
Abstract

Patients with ulcerative colitis have an increased risk for developing colon cancer compared to the general population. The risk is related to the extension of the disease and its duration. This risk is the same for Crohn's colitis patients of equal extension and duration. By chemoprevention we mean the use of specific natural or synthetic chemical agents to reverse, suppress or prevent progression to invasive cancer. The chemopreventive agents for colon cancer are either of natural origin (vitamins, minerals, food constituents) or synthetic chemicals (difluoromethyl ornithine) and pharmaceutical agents (aspirin, oltipraz). Apart from folate, no other agent has so far been used in vivo for the prevention of colon cancer in long-standing inflammatory bowel disease. The use of folate was, however, not primarily intended to prevent cancer but to enhance folate absorption in ulcerative colitis. From retrospective studies, within the framework of cancer surveillance programmes, it became evident that folate supplementation may play a positive role as a chemopreventive agent against colorectal cancer in patients with long-standing, extensive ulcerative colitis. There is also evidence suggesting that folate supplementation may contribute to regulation of rectal cell proliferation in ulcerative colitis patients. There is a real need for multicentre, randomized, prospective clinical studies in order to evaluate the promising role of folate in preventing colorectal cancer in patients with long-standing inflammatory bowel disease.

摘要

与普通人群相比,溃疡性结肠炎患者患结肠癌的风险增加。这种风险与疾病的范围及其持续时间有关。对于病变范围和持续时间相同的克罗恩结肠炎患者,这种风险是一样的。化学预防是指使用特定的天然或合成化学制剂来逆转、抑制或预防进展为浸润性癌。用于结肠癌的化学预防剂要么是天然来源的(维生素、矿物质、食物成分),要么是合成化学物质(二氟甲基鸟氨酸)以及药物制剂(阿司匹林、奥替普拉)。除了叶酸,到目前为止还没有其他制剂在体内用于预防长期炎症性肠病患者的结肠癌。然而,使用叶酸主要目的不是预防癌症,而是提高溃疡性结肠炎患者的叶酸吸收。从癌症监测项目框架内的回顾性研究中可以明显看出,补充叶酸可能作为化学预防剂对长期广泛性溃疡性结肠炎患者预防结直肠癌起到积极作用。也有证据表明,补充叶酸可能有助于调节溃疡性结肠炎患者直肠细胞的增殖。确实需要进行多中心、随机、前瞻性临床研究,以评估叶酸在预防长期炎症性肠病患者结直肠癌方面的潜在作用。

相似文献

1
Chemoprevention of colorectal cancer in inflammatory bowel disease? A potential role for folate.炎症性肠病中结直肠癌的化学预防?叶酸的潜在作用。
Ital J Gastroenterol Hepatol. 1998 Aug;30(4):421-5.
2
Chronic inflammatory bowel disease and cancer.慢性炎症性肠病与癌症
Hepatogastroenterology. 2000 Jan-Feb;47(31):57-70.
3
Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.综述文章:氨基水杨酸盐和免疫调节对炎症性肠病患者癌症风险的影响
Aliment Pharmacol Ther. 2006 Oct;24 Suppl 3:64-7. doi: 10.1111/j.1365-2036.2006.03063.x.
4
[Inflammatory bowel disease and colorectal cancer].[炎症性肠病与结直肠癌]
Orv Hetil. 2006 Oct 15;147(41):1977-82.
5
Chemoprevention for colon cancer: new opportunities, fact or fiction?结肠癌的化学预防:新机遇,事实还是虚构?
Scand J Gastroenterol Suppl. 2006(243):158-64. doi: 10.1080/00365520600664284.
6
[Colorectal cancer in inflammatory bowel disease].[炎症性肠病中的结直肠癌]
Tidsskr Nor Laegeforen. 2007 Oct 18;127(20):2696-9.
7
Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.结直肠癌与炎症性肠病:流行病学、危险因素、致癌机制及预防策略
Anticancer Res. 2009 Jul;29(7):2727-37.
8
Colon cancer surveillance.结肠癌监测
Gastroenterol Clin North Am. 1995 Sep;24(3):671-87.
9
Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.炎症性肠病患者队列中临床参数与结直肠癌-结肠炎间隔时间的关系
Scand J Gastroenterol. 2009;44(1):46-55. doi: 10.1080/00365520801977568.
10
Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.化学预防:通过药物治疗炎症性肠病降低风险
Gastroenterol Clin North Am. 2006 Sep;35(3):675-712. doi: 10.1016/j.gtc.2006.07.003.

引用本文的文献

1
Folate concentrations in pediatric patients with newly diagnosed inflammatory bowel disease.新诊断的炎症性肠病儿科患者的叶酸浓度
Am J Clin Nutr. 2009 Feb;89(2):545-50. doi: 10.3945/ajcn.2008.26576. Epub 2008 Dec 30.
2
5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease.5-氨基水杨酸是炎症性肠病患者结肠癌化学预防的一种有吸引力的候选药物。
World J Gastroenterol. 2005 Jan 21;11(3):309-14. doi: 10.3748/wjg.v11.i3.309.
3
Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma.
在化学诱导的肝细胞癌体内模型中,阿司匹林可抑制肺转移,而吲哚美辛则不能。
Jpn J Cancer Res. 2002 Oct;93(10):1175-81. doi: 10.1111/j.1349-7006.2002.tb01220.x.